The Economic Times daily newspaper is available online now.

    J&J expects COVID vaccine sales to jump as much as 46% in 2022

    Synopsis

    Johnson & Johnson said on Tuesday it expects to generate as much as $3.5 billion from the sale of its COVID-19 vaccine this year compared to $2.39 billion in 2021, in a sign of easing manufacturing problems and increasing demand.

    FILE PHOTO: Vials and medical syringe are seen in front of J&J logo in this illustration
    FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration
    Johnson & Johnson said on Tuesday it expects to generate as much as $3.5 billion from the sale of its COVID-19 vaccine this year compared to $2.39 billion in 2021, in a sign of easing manufacturing problems and increasing demand.

    Delivery delays and an uneven demand during last year resulted in the drugmaker narrowly missing its goal of garnering $2.50 billion in vaccine sales in 2021.
    J&J shares fell 1.2% before the opening bell as overall fourth-quarter sales also missed market expectations due to a bleak performance by a few of the big revenue drivers such as cancer drug Imbruvica and Crohn's disease treatment Stelara.

    Contributions from the coronavirus vaccine are expected to be a small part of J&J's overall sales as the company sells it at a not-for-profit price.

    Rivals Pfizer and Moderna, however, have benefited from sales of their vaccines, forecasting multi-billion dollars in revenue from their shots in 2021 and 2022.

    J&J's forecast comes at a time when it looks to separate its consumer health unit and focus on medical devices and pharmaceuticals businesses.

    Sales of J&J's and AbbVie's cancer drug Imbruvica came in at $1.06 billion, below Wall Street estimates of $1.17 billion. Stelara sales of $2.33 billion also missed estimates of $2.45 billion.

    Overall sales of $24.80 billion missed expectations of $25.29 billion, according to Refinitiv data.



    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News, Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more

    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News, Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more
    The Economic Times

    Stories you might be interested in